(Q45623559)

14 December 2017

title

Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus (English)

1 reference

14 December 2017

main subject

Mycobacterium kansasii

object named as

Mycobacterium kansasii

1 reference

Theodore K Marras

1

1 reference

14 December 2017

Alison Morris

series ordinal

2

1 reference

14 December 2017

Leah C Gonzalez

series ordinal

3

1 reference

14 December 2017

Charles L Daley

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

23 June 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

14 December 2017

published in

1 reference

14 December 2017

volume

170

1 reference

14 December 2017

issue

7

1 reference

14 December 2017

page(s)

793-798

1 reference

Mycobacterium kansasii disease in patients infected with human immunodeficiency virus

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Epidemiology of human pulmonary infection with nontuberculous mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Mycobacterium kansasii: A Cause of Treatable Pulmonary Disease Associated with Advanced Human Immunodeficiency Virus (HIV) Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Clinical Manifestations and Implications of Coinfection with Mycobacterium kansasii and Human Immunodeficiency Virus Type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Mycobacterium kansasii and human immunodeficiency virus co-infection in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Kansas City AIDS Research Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-162OC

10.1164/RCCM.200402-162OC

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference